1161499-39-3Relevant articles and documents
Cathepsin C inhibitors: Property optimization and identification of a clinical candidate
Furber, Mark,Tiden, Anna-Karin,Gardiner, Philip,Mete, Antonio,Ford, Rhonan,Millichip, Ian,Stein, Linda,Mather, Andrew,Kinchin, Elizabeth,Luckhurst, Christopher,Barber, Simon,Cage, Peter,Sanganee, Hitesh,Austin, Rupert,Chohan, Kamaldeep,Beri, Raj,Thong, Bob,Wallace, Alan,Oreffo, Victor,Hutchinson, Ray,Harper, Steve,Debreczeni, Judit,Breed, Jason,Wissler, Lisa,Edman, Karl
, p. 2357 - 2367 (2014/04/17)
A lead generation and optimization program delivered the highly selective and potent CatC inhibitor 10 as an in vivo tool compound and potential development candidate. Structural studies were undertaken to generate SAR understanding.
PEPTIDYL NITRILES AND USE THEREOF AS DIPEPTIDYL PEPTIDASE I INHIBITORS
-
Page/Page column 91-92, (2009/07/17)
The present invention provides compounds of formula (I) in which n, y, X1, X2, A, B, R1, R2, R3, R4 and R5 are as defined in the specification, a process for their preparation, pharmaceutical compositions containing them and their use as dipeptidyl peptidase I (DPPI) inhibitors.